|
Lawrence Goldstein,
Director,
University of California San Diego
Linda Powers
Managing Director
Toucan Capital Investments, USA
Susan Lim
Chief Executive Officer
Stem Cell technologies i, Singapore
Alok Srivastava
Professor and Head,
Christian Medical College. India
|
|
|
|
World Stem Cells & Regenerative Medicine Congress Asia 2009
The only stem cell event in Asia that brings Science and Business together where global and Asian pharmas, biotechs, academics and investors gather to discuss innovation, market opportunities and partnership models
|
Download the brochure!
Stem Cells and Regenerative Medicines Congress Asia will bring together global and regional pharma, biotechs, investors and academic scientific leaders who are in the stem cell and regenerative medicines field to uncover Asia’s market potential, scientific capability and opportunities for collaborations in fast-tracking research development and commercialization of stem cell therapies and applications in the global marketplace. In addition, the event will address the potential of Asia as a hub for effective conduct research, clinical development and manufacturing.
Get Ready! Find out how to take stem cell research from bench to bedside in Asia-Pacific
Be Informed! Learn about the latest breakthroughs and developments in regenerative medicine from 20+ Asian Pacific institutions
Know the right people! Meet key players in the commercialization process from Asia-Pacific's top 8 countries
» More about the conference
» Who should attend?
» Reserve your seat now
|
Meet and network with the following speakers:
 Dr Paul Verma,
Senior Scientist,
Monash University, Australia
|
 Dr Kerry Atkinson,Director, Biotherapy program,
Mater Medical Research Institute, Australia
|
Mr. Douglas Sipp,
Manager, Scientific Communication and International Affairs,
Riken Center for Developmental Biology, Japan
|
 Dr. Christopher Mason,Director, Regenerative Medicine Bioprocessing Unit,
University College London, United Kingdom
|
Dr. Silviu Itescu,
Chief Executive Officer,
Mesoblast
|
Dr David Smith,
Vice President of Cell Therapy,
Lonza
|
Executive Director,
A*Star Biomedical Research Council, Singapore
|
Group Leader,
Monash University, Australia
|
|
 |
|
|
|
|
